Cancer associated fibroblasts: phenotypic and functional heterogeneity

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment Research

Background:

• Cancer associated fibroblasts (CAFs) are the predominant stromal cells within solid tumors.
• CAFs significantly influence tumor progression through cell-cell interactions and extracellular matrix remodeling.
• Recent evidence highlights heterogeneity within CAF populations, challenging their uniform role.

Purpose of the Study:

• To summarize recent findings on the mechanisms underlying CAF heterogeneity.
• To explore how heterogeneous CAFs act as either positive or negative regulators of tumor progression.
• To briefly review targeted therapies against CAF-mediated mechanisms.

Main Methods:

• Literature review of recent studies on CAF heterogeneity.
• Analysis of mechanisms by which CAFs influence tumor progression.
• Summary of emerging targeted therapeutic strategies against CAFs.

Main Results:

• CAF heterogeneity is a critical factor influencing tumor progression.
• CAFs can exhibit both tumor-promoting and tumor-suppressing roles depending on their subtype.
• Targeting specific CAF-mediated mechanisms shows therapeutic potential.

Conclusions:

• Understanding CAF heterogeneity is crucial for developing effective cancer therapies.
• Exploiting CAF diversity may lead to novel treatment strategies.
• Targeted therapies against CAFs represent a promising avenue in oncology.